Open original FDA record ↗Recall record
- FDA identifier
- Z-1060-2019
- Company in FDA record
- GE Healthcare, LLC
- FDA record creation date
- Mar 26, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
The Integrated ECG cable with 3-lead leadwires can short circuit during defibrillation and conduct 25% of the defibrillation energy away from the patient.
Source facts
- Action
- Consignees were initially notified via telephone call on about 02/22/2019 and followed up with an "URGENT MEDICAL DEVICE CORECTION" letter. Instructions included to immediately stop use of the affected Integrated ECG cables and quarantine any on hand. GE Healthcare will replace all affected cables at no cost and a GE Healthcare representative will contact each customer to arrange for the collection of the affected cables and provide replacement of new cables. Questions or concerns can be directed to GE Healthcare Service at 1-800-437-1171.
- Initiated
- 2019-02-22
- Root cause
- Under Investigation by firm
- Terminated
- 2020-08-19
- Distribution
- Worldwide Distribution - US Nationwide to AK, KS, MA, MA, ME, NJ, NJ, NM, NY, TX. Distributed worldwide to Chile, Finland, France, Germany, Italy, Korea (Republic Of), Russia, Spain, Sweden.
- Recall number
- Z-1060-2019
- Recall status
- Terminated
- CDRH record ID
- 171255
- FDA record created
- 2019-03-26
- Recall event number
- 82272